Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Agnelli

Showing results (121-130 of 202) with videos related to

Pageof 21
Sort By:
Thrombosis and Haemostasis|October 1, 1995
Clinical outcome of orthopaedic patients with negative lower limb venography at dischargeG Agnelli, V Ranucci, F Veschi, et al.
Thrombosis and Haemostasis|August 2, 1993
Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935)G Agnelli, C Pascucci, G G Nenci, et al.
Thrombosis and Haemostasis|June 30, 1989
Additive effect of dDAVP and standard heparin in increasing plasma t-PAG Agnelli, M Levi, B Cosmi, et al.
Nephron|January 1, 1979
Effect of peritoneal dialysis, haemodialysis and kidney transplantation on blood platelet function. I. Platelet aggregation by ADP and epinephrineG G Nenci, M Berrettini, G Agnelli, et al.
Investigative Radiology|May 1, 1990
Effect on thrombus growth and thrombolysis of two types of osmolar contrast media in rabbitsM Levi, C Pascucci, G Agnelli, et al.
Thrombosis and Haemostasis|January 11, 1993
A hybrid plasminogen activator binds to the u-PA receptor and has a reduced thrombolytic potency in vivoF A Asselbergs, R Bürgi, J Hamerman, et al.
Journal of Thrombosis and Haemostasis : JTH|January 31, 2013
Incidental venous thromboembolism in oncology patientsA A Khorana, C O'Connell, G Agnelli, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
Mechanisms of the antimetastatic activity of stable prostacyclin analogues: modulation of host immunocompetenceV Costantini, A Giampietri, M Allegrucci, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Platelet-tumor cell interaction: effect of prostacyclin and a synthetic analog on metastasis formationV Costantini, P Fuschiotti, M Allegrucci, et al.
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|February 13, 2002
[Comments on the guidelines of the European Society of Cardiology Task Force on pulmonary embolism]P Zonzin, G Agnelli, F Casazza, et al.
Pageof 21

Showing results (121-130 of 202) with videos related to

Sort By:
Pageof 21
Thrombosis and Haemostasis|October 1, 1995
Clinical outcome of orthopaedic patients with negative lower limb venography at dischargeG Agnelli, V Ranucci, F Veschi, et al.
Thrombosis and Haemostasis|August 2, 1993
Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935)G Agnelli, C Pascucci, G G Nenci, et al.
Thrombosis and Haemostasis|June 30, 1989
Additive effect of dDAVP and standard heparin in increasing plasma t-PAG Agnelli, M Levi, B Cosmi, et al.
Nephron|January 1, 1979
Effect of peritoneal dialysis, haemodialysis and kidney transplantation on blood platelet function. I. Platelet aggregation by ADP and epinephrineG G Nenci, M Berrettini, G Agnelli, et al.
Investigative Radiology|May 1, 1990
Effect on thrombus growth and thrombolysis of two types of osmolar contrast media in rabbitsM Levi, C Pascucci, G Agnelli, et al.
Thrombosis and Haemostasis|January 11, 1993
A hybrid plasminogen activator binds to the u-PA receptor and has a reduced thrombolytic potency in vivoF A Asselbergs, R Bürgi, J Hamerman, et al.
Journal of Thrombosis and Haemostasis : JTH|January 31, 2013
Incidental venous thromboembolism in oncology patientsA A Khorana, C O'Connell, G Agnelli, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
Mechanisms of the antimetastatic activity of stable prostacyclin analogues: modulation of host immunocompetenceV Costantini, A Giampietri, M Allegrucci, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Platelet-tumor cell interaction: effect of prostacyclin and a synthetic analog on metastasis formationV Costantini, P Fuschiotti, M Allegrucci, et al.
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|February 13, 2002
[Comments on the guidelines of the European Society of Cardiology Task Force on pulmonary embolism]P Zonzin, G Agnelli, F Casazza, et al.
Pageof 21